| Literature DB >> 29108342 |
Yingjie Zhang1,2, Jianbin Li1,2, Yili Duan3, Wei Wang1,2, Fengxiang Li1,2, Qian Shao1,2, Min Xu1,2.
Abstract
Fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) and four-dimensional CT (4DCT) are used in several methods for defining the biological target volume (BTV) in primary non-small cell lung cancer (NSCLC). Disagreements between the assessments using these methodologies make the use of BTV for radiotherapy planning controversial. In this study, we compared existing methods with our proposed internal biological target volume (IBTV) metric, derived by combining internal target volume (ITV) and BTV metrics. We defined the IBTV from ITV (IBTVi) or BTV (IBTVb) based on ITV or BTV with symmetrical margin expansion. We detected large differences between IBTV, IBTVi and IBTVb (p < 0.001), but no difference between ITV and BTV. A margin expansion of about 13 mm was necessary for ITV or BTV to encompass > 95% IBTV. The conformity index correlated negatively with IBTV/ITV, IBTV/BTV, IBTVi/ITV, and IBTVb/BTV volume ratios (p < 0.05). VR also increased the margins of IBTVi and IBTVb. Indeed, IBTV was much smaller than IBTVi or IBTVb, suggesting that using IBTV for radiotherapy planning could improve treatment by minimizing the radiation exposure of healthy tissue and organs surrounding tumors.Entities:
Keywords: 18F-Fluorodeoxyglucose positron emission tomography CT (18F-FDG PET-CT); four-dimensional computed tomography (4DCT); internal biological target volume (IBTV); non-small cell lung cancer (NSCLC)
Year: 2017 PMID: 29108342 PMCID: PMC5668075 DOI: 10.18632/oncotarget.18917
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1Personal target volume of BTV, ITV, IBTV, IBTVi and IBTVb
Volume ratio of targets
| Mean | SD | 95% lower limit | 95% upper limit | |
|---|---|---|---|---|
| 1.38 | 0.22 | 1.26 | 1.50 | |
| 5.10 | 2.53 | 3.70 | 6.50 | |
| 1.33 | 0.19 | 1.23 | 1.43 | |
| 4.54 | 1.90 | 3.49 | 5.59 |
1VR: volume ratio.
A correlation analysis of the target volume and displacement
| V1 | DITV-BTV2 | CI3 | BTV4 | ITV5 | VRIBTV/ITV6 | VRIBTV/BTV | VRIBTVi/ITV | VRIBTVb/BTV | MITV7 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DITV-BTV | 0.431 | ||||||||||
| 0.109 | . | ||||||||||
| CI | −0.139 | −0.415 | |||||||||
| 0.621 | 0.124 | . | |||||||||
| BTV | 0.193 | −0.213 | 0.575 | ||||||||
| 0.491 | 0.447 | 0.025 | . | ||||||||
| ITV | 0.307 | −0.150 | 0.593 | 0.954 | |||||||
| 0.265 | 0.593 | 0.020 | 0.000 | . | |||||||
| VRIBTV/ITV | 0.079 | 0.322 | −0.732 | −0.129 | −0.318 | ||||||
| 0.781 | 0.242 | 0.002 | 0.648 | 0.248 | . | ||||||
| VRIBTV/BTV | 0.346 | 0.565 | −0.639 | −0.336 | −0.168 | 0.107 | |||||
| 0.206 | 0.028 | 0.010 | 0.221 | 0.550 | 0.704 | . | |||||
| VRIBTVi/ITV | −0.200 | 0.127 | −0.704 | −0.489 | −0.621 | 0.718 | 0.125 | ||||
| 0.475 | 0.652 | 0.003 | 0.064 | 0.013 | 0.003 | 0.657 | . | ||||
| VRIBTVb/BTV | 0.043 | 0.345 | −0.657 | −0.464 | −0.336 | 0.179 | 0.682 | 0.193 | |||
| 0.879 | 0.208 | 0.008 | 0.081 | 0.221 | 0.524 | 0.005 | 0.491 | . | |||
| MITV | 0.184 | −0.021 | −0.298 | 0.271 | 0.101 | 0.647 | −0.089 | 0.611 | −0.220 | ||
| 0.511 | 0.941 | 0.280 | 0.329 | 0.720 | 0.009 | 0.754 | 0.016 | 0.430 | . | ||
| MBTV8 | 0.399 | 0.227 | −0.159 | 0.408 | 0.519 | 0.058 | 0.435 | −0.247 | 0.565 | 0.031 | |
| 0.141 | 0.415 | 0.572 | 0.132 | 0.047 | 0.838 | 0.105 | 0.375 | 0.028 | 0.913 |
1V: the tumor motion vector.
2DITV-BTV: the distance between ITV and BTV.
3CI: concordance index defined as the formula: CI (A/B) = (A∩B)/(AUB)
4BTV: biological target volume with threshold of SUV ≥ 2.0
5ITV: internal target volume composed of GTVs delineated on the 10 phases of four-dimensional CT.
6VRA/B: volume ratio of target A to B.
7MITV: a margin from ITV expanding to ITVi.
8MBTV: a margin from BTV expanding to ITVb.
Figure 2Schematic diagram to construct IBTVs by three metrics
Patient characteristics and tumor volume variations
| Case | Sex | Age (y) | Tumor location | History | Tumor Stage | SUVmax1 | GTV2 | BTV3 | ITV4 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 66 | U5 | A7 | T2 | 25.51 | 16.67 | 32.75 | 24.50 |
| 2 | F | 68 | L6 | AS8 | T3 | 11.00 | 142.89 | 135.47 | 173.72 |
| 3 | M | 70 | U | A | T2 | 7.71 | 5.05 | 7.67 | 5.90 |
| 4 | M | 79 | U | A | T1 | 8.80 | 26.94 | 31.11 | 37.66 |
| 5 | F | 49 | L | S9 | T2 | 8.85 | 38.70 | 49.45 | 44.01 |
| 6 | M | 66 | U | S | T2 | 14.41 | 17.24 | 20.46 | 22.31 |
| 7 | M | 75 | U | S | T2 | 12.39 | 14.53 | 18.07 | 19.99 |
| 8 | F | 65 | U | A | T2 | 13.41 | 7.79 | 13.03 | 9.80 |
| 9 | M | 76 | L | S | T4 | 15.13 | 109.84 | 201.56 | 152.80 |
| 10 | M | 84 | L | A | T2 | 24.81 | 28.74 | 39.27 | 33.16 |
| 11 | M | 65 | U | A | T4 | 14.38 | 40.06 | 48.46 | 57.53 |
| 12 | F | 67 | U | A | T1 | 6.99 | 6.34 | 10.84 | 11.70 |
| 13 | M | 65 | U | S | T4 | 14.52 | 154.12 | 152.57 | 164.10 |
| 14 | M | 45 | U | A | T1 | 6.09 | 5.07 | 5.91 | 7.00 |
| 15 | M | 60 | U | S | T3 | 11.34 | 20.35 | 33.02 | 26.15 |
1SUVmax: maximal standardized uptake value.
2GTV: gross target volume delineated on 3D-CT.
3BTV: biological target volume with threshold of SUV ≥ 2.0.
4ITV: internal target volume composed of GTVs delineated on the 10 phases of four-dimensional CT.
5U: Upper lobe.
6L: Lower lobe.
7A: Adenocarcinoma.
8AS: Adenosquamous carcinoma.
9S: Squamous carcinoma.